"These findings may inform shared decision making when considering GLP- 1 receptor agonist therapy and highlight the need for further evaluation of dermatological outcomes in future studies." The study involved a large number of people: 12,004 patients using GLP-1 drugs were compared to 15,221 using SGLT-2 inhibitors, with an additional 11,964 GLP-1 users compared to 11,233 using DPP-4 inhibitors
(March 2023)
As we noted in a recent GLP1-s white paper, the longterm commercial implications of these actions remain unclear
Tkalevi VI, ui S, Braja K, Mildner B, Bokuli A, itum K, et al
Consequently, GSH depletion prevented the LPS-induced activation of antiviral response and its inhibition of influenza virus infection